HONG KONG, Aug. 17, 2017 /PRNewswire/ -- China Cord Blood
Corporation (NYSE: CO) (the "Company") today announced that it
plans to release its preliminary unaudited first quarter fiscal
2018 financial results on Wednesday, August
23, 2017, after the market close.
The Company will host a conference call at 8:00 a.m. ET on Thursday,
August 24, 2017 to discuss its financial performance and
give a brief overview of the Company's recent developments,
followed by a question and answer session. Interested parties can
access the audio webcast through the Company's IR website at
http://ir.chinacordbloodcorp.com. A replay of the webcast will be
accessible two hours after the conference call and available for
three weeks at the same URL as above. Listeners can also access the
call by dialing 1-719-325-2213 or 1-866-564-2842, for US callers,
or +852-3008-1527, for Hong Kong
callers, access code: 2659383.
Please dial in ten minutes prior to the conference call to
ensure proper connection, and be prepared to provide your name and
company name to the operator.
Supplemental financial information referenced in the conference
call and the first quarter of fiscal 2018 earnings press release
will be available at http://www.chinacordbloodcorp.com, in the
section titled "Investor Center/Press Release", after 4:16 p.m. ET on Wednesday,
August 23, 2017, and in the Company's Report on Form 6-K for
the month of August 2017, available
on the Securities and Exchange Commission's website at
www.sec.gov.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest umbilical
cord blood banking operator in China in terms of geographical coverage and
the only cord blood banking operator with multiple licenses.
Under current PRC government regulations, only one licensed cord
blood banking operator is permitted to operate in each licensed
region and no new licenses will be granted before 2020 in addition
to the seven licenses authorized as of today. China Cord
Blood Corporation provides cord blood collection, laboratory
testing, hematopoietic stem cell processing, and stem cell storage
services. For more information, please visit our website at
http://www.chinacordbloodcorp.com.
For more information, please contact:
China Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@chinacordbloodcorp.com
ICR, Inc.
William Zima
Tel: (+86) 10-6583-7511
U.S. Tel: (646) 405-5185
Email: william.zima@icrinc.com
View original
content:http://www.prnewswire.com/news-releases/china-cord-blood-corporation-to-report-first-quarter-fiscal-2018-financial-results-300505906.html
SOURCE China Cord Blood Corporation